Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sumei Gu"'
Autor:
Kevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, Carlijn M van der Aalst, Sumei Gu, S Elizabeth McGregor, Garth Nicholas, Harry J de Koning, Lawrence F Paszat
Publikováno v:
PLoS Medicine, Vol 14, Iss 2, p e1002225 (2017)
BACKGROUND:The National Lung Screening Trial (NLST) results indicate that computed tomography (CT) lung cancer screening for current and former smokers with three annual screens can be cost-effective in a trial setting. However, the cost-effectivenes
Externí odkaz:
https://doaj.org/article/23118810297e42b8808708714002ed8a
Autor:
Ying Dai, Fang Tang, Yanqin Mao, Na He, Meimei Yu, Mengjiao Zhang, Sumei Gu, Yin Lu, Jingjing Shang, Xiamin Zhu
Publikováno v:
Medicine; 11/24/2023, Vol. 102 Issue 47, p1-3, 3p
Autor:
Sumei Gu, Eileen Rakovitch, Lawrence Paszat, Mira Goldberg, Cindy Fong, Timothy J. Whelan, Rinku Sutradhar
Publikováno v:
Cancer Research. 80:P2-18
Purpose: Current guidelines recommend for women (≥65 years at diagnosis) with early stage (T1N0), hormone receptor (HR+) breast cancer (BC) treated with breast-conserving surgery (BCS) that treatment with 5 years of endocrine therapy (ET) alone wit
Autor:
Eileen Rakovitch, Sumei Gu, Mira Goldberg, Cindy Fong, Rinku Sutradhar, Timothy J. Whelan, Lawrence Paszat
Publikováno v:
Cancer Research. 80:P5-12
Purpose: Clinical guidelines recommend that for women ≥65 years with stage T1N0 breast cancer (BC) treated with breast-conserving surgery (BCS) that breast RT may be omitted and treatment with ET alone is acceptable. However, population-based studi
Autor:
Danielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, Sumei Gu, Neil Faught, Ezra Hahn, Cindy Fong, Sabina Trebinjac, Lawrence Paszat, Eileen Rakovitch
Publikováno v:
Breast cancer research and treatment. 192(1)
The paucity of data on women with large (≥ 40 mm) DCIS tumors lead to uncertainty on the safety of breast-conserving surgery (BCS) for these patients. We evaluated the impact of large tumor size on local recurrence (LR) among women with DCIS treate
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 26:1401-1410
Background: A population-based program promoting the Fecal Occult Blood Test (FOBT) for colorectal cancer screening was introduced in 2008 in Ontario, Canada, where opportunistic screening with colonoscopy had been increasing in frequency. We evaluat
Autor:
Doris, Howell, Madeline, Li, Rinku, Sutradhar, Sumei, Gu, Javaid, Iqbal, Mary Ann, O'Brien, Hsien, Seow, Deborah, Dudgeon, Clare, Atzema, Craig C, Earle, Carlo, DeAngelis, Jonathan, Sussman, Lisa, Barbera
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 28(10)
The use of patient-reported outcomes (PROs) for routine cancer distress screening is endorsed globally as a quality-care standard. However, there is little research on the integration of PROs in "real-world" oncology practices using implementation sc
Autor:
Xiangjing Meng, Sumei Guo, Xiaoxia Zhang, Bo Jiao, Xiaohan Yang, Ming Li, Chao Li, Jin He, Shangya Chen, Cheng Peng, Hua Shao, Qiang Jia
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 266, Iss , Pp 115575- (2023)
Exposure to toluene diisocyanate (TDI) can cause pulmonary diseases such as asthma. Inhibition of high mobility group box 1 protein (HMGB1) has been found to be protective against the toxic effects of TDI on human bronchial epithelial (HBE) cells. He
Externí odkaz:
https://doaj.org/article/a8b3df96fe7b49299c62de151fdbc545
Autor:
Rinku Sutradhar, Linda Rabeneck, Lieke Hol, Nancy N. Baxter, Lawrence Paszat, Jill Tinmouth, Sumei Gu
Publikováno v:
CMAJ Open. 3:E244-E250
BACKGROUND: Data suggest the overuse of repeat colonoscopies, especially in patients at low risk for colorectal cancer. Our objective was to evaluate the time to repeat colonoscopies in low-risk patients aged 50-79 years old and the associated patien
Autor:
Kevin ten Haaf, Susan J. Bondy, Sumei Gu, S. Elizabeth McGregor, Carlijn M. van der Aalst, Harry J. de Koning, Martin C. Tammemägi, Lawrence Paszat, Garth Nicholas
Publikováno v:
PLoS Medicine
PLoS Medicine (online), 14(2):e1002225. Public Library of Science
PLoS Medicine, Vol 14, Iss 2, p e1002225 (2017)
PLoS Medicine (online), 14(2):e1002225. Public Library of Science
PLoS Medicine, Vol 14, Iss 2, p e1002225 (2017)
Background The National Lung Screening Trial (NLST) results indicate that computed tomography (CT) lung cancer screening for current and former smokers with three annual screens can be cost-effective in a trial setting. However, the cost-effectivenes